Literature DB >> 33856512

Crystallized phenol for treatment of pilonidal sinus disease in children: a comparative clinical study.

Serkan Arslan1, Mehmet Hanifi Okur2, Erol Basuguy2, Bahattin Aydogdu2, Hikmet Zeytun3, Suat Cal2, Serdest Tegin2, Mustafa Azizoglu2.   

Abstract

BACKGROUND: The aim of this study was to present our experience in the use of crystallized phenol (CP) to treat pediatric patients with 'simple' and complex' Pilonidal sinus disease (PSD).
MATERIALS AND METHODS: Patients who underwent CP treatment in between January 2015 and January 2020 were evaluated retrospectively, using prospectively collected data. The patients were divided into simple and complicated groups. The groups were assigned depending on the number of sinuses and clinical presentation. The groups were compared in terms of age, sex, number of sessions, cost analysis, body mass index (BMI), recurrence, time resolution, cosmetic results, results /improvement, and complications.
RESULTS: This study included 54 patients: 28 (52%) girls and 26 (48%) boys. The mean number of sinuses was 2.4. Symptoms included discharge in 50 (92%) patients, and pain in 42 (78%) patients. Fifty (93%) patients experienced mild pain during the procedure, whereas four (7%) patients had moderate pain. The mean number of CP sessions was 2.9; mean numbers of CP sessions were 2.2 and 4.2 in the Simple and Complicated groups. In total, 5 of 54 patients (9%) had recurrence.At the end of treatment, therapeutic success was achieved in 49 of 54 (91%) patients: 31 of 33 (94%) patients in the Simple group and 18 of 21 patients (86%) in the complicated group. The mean treatment cost for the whole cohort was $17.40. One patient (2%) presented with moderate skin burns. Cosmesis was deemed acceptable by patients, although there was evidence of minor skin burns following the procedure.
CONCLUSIONS: The findings showed that the CP procedure was advantageous for treatment of PSD, because it was minimally invasive, cost-effective, provided good cosmesis, and had a high success rate and low complication rate. Furthermore, it did not require prior examination, and could be performed under local anesthesia. Therefore, the CP procedure may be useful as a first-line treatment option in children with PSD.

Entities:  

Keywords:  Children; Crystallized; Disease; Phenol; Pilonidal; Sinus

Mesh:

Substances:

Year:  2021        PMID: 33856512     DOI: 10.1007/s00383-020-04798-7

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  14 in total

1.  Crystallized phenol in nonoperative treatment of previously operated, recurrent pilonidal disease.

Authors:  Erhan Aygen; Kemal Arslan; Osman Dogru; Murat Basbug; Cemalettin Camci
Journal:  Dis Colon Rectum       Date:  2010-06       Impact factor: 4.585

2.  The results of a one-time crystallized phenol application for pilonidal sinus disease.

Authors:  Mustafa Girgin; Burhan Hakan Kanat
Journal:  Indian J Surg       Date:  2012-06-16       Impact factor: 0.656

3.  Minimally invasive treatment of pilonidal disease: crystallized phenol and laser depilation.

Authors:  Mustafa Girgin; Burhan Hakan Kanat; Refik Ayten; Ziya Cetinkaya; Zekiye Kanat; Ahmet Bozdağ; Ahmet Turkoglu; Yavuz Selim Ilhan
Journal:  Int Surg       Date:  2012 Oct-Dec

4.  Crystallized phenol treatment of pilonidal disease improves quality of life.

Authors:  Omer Topuz; Selim Sözen; Mustafa Tükenmez; Sezgin Topuz; Umit Erkan Vurdem
Journal:  Indian J Surg       Date:  2012-06-29       Impact factor: 0.656

5.  Phenol Injection Versus Excision With Open Healing in Pilonidal Disease: A Prospective Randomized Trial.

Authors:  Ismail Calikoglu; Kamil Gulpinar; Derya Oztuna; Atilla Halil Elhan; Osman Dogru; Cihangir Akyol; Bulent Erkek; Mehmet Ayhan Kuzu
Journal:  Dis Colon Rectum       Date:  2017-02       Impact factor: 4.585

6.  Timeline of recurrence after primary and secondary pilonidal sinus surgery.

Authors:  Dietrich Doll; Colin M Krueger; Stefan Schrank; Heidi Dettmann; Sven Petersen; Wolfgang Duesel
Journal:  Dis Colon Rectum       Date:  2007-11       Impact factor: 4.585

7.  Endoscopic pilonidal sinus treatment (E.P.Si.T.).

Authors:  P Meinero; L Mori; G Gasloli
Journal:  Tech Coloproctol       Date:  2013-05-17       Impact factor: 3.781

8.  Endoscopic pilonidal sinus treatment: a prospective multicentre trial.

Authors:  P Meinero; A Stazi; A Carbone; F Fasolini; L Regusci; M La Torre
Journal:  Colorectal Dis       Date:  2016-05       Impact factor: 3.788

9.  Unroofing and marsupialization vs. rhomboid excision and Limberg flap in pilonidal disease: a prospective, randomized, clinical trial.

Authors:  Feza Karakayali; Erdal Karagulle; Zulfikar Karabulut; Ergun Oksuz; Gokhan Moray; Mehmet Haberal
Journal:  Dis Colon Rectum       Date:  2009-03       Impact factor: 4.585

10.  Minimally Invasive Surgical Treatment of Pilonidal Disease: Mid-Term Retrospective Analysis of a Single Center.

Authors:  Ana Isabel Oliveira; Catarina Barroso; Angélica Osório; Jorge Correia-Pinto
Journal:  Front Pediatr       Date:  2019-06-04       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.